STE · 8-K · 20260805PR053412

Restructuring and Facility Consolidation

STERIS plc · 2026-08-05 · Importance 52 · Surprise 42 · In source text

STERIS announced a targeted restructuring plan tied to a new Formulated Chemistries Center of Excellence in North Carolina. The plan anticipates closing chemistry manufacturing and distribution facilities in St. Louis, Missouri, and Plymouth, Minnesota, after consolidation is complete. Total pre-tax restructuring charges are expected to be approximately $55 million to $70 million through fiscal 2030, including $40 million to $50 million of cash expenditures and $15 million to $20 million of non-cash charges. Cash costs will primarily cover associate retention, severance, benefits, transition, and facility-exit expenses, while non-cash charges will primarily reflect accelerated depreciation.

Key facts

• The Company currently expects to incur total pre-tax restructuring charges of approximately $55 million to $70 million, consisting of approximately $40 million to $50 million of cash expenditures and approximately $15 million to $20 million of non-cash charges. source
• STERIS announced a targeted restructuring plan to consolidate manufacturing and distribution for formulated chemistries to a new Center of Excellence in North Carolina. source
• Once complete, the plan includes the anticipated closure of chemistry manufacturing and distribution facilities in St. Louis, Missouri, and Plymouth, Minnesota. source
• Cash expenditures related to the restructuring are expected to primarily consist of Associate retention, severance and benefits, and also include transition, facility exit and other related costs. source
• Non-cash charges are expected to primarily relate to accelerated depreciation. source
• Restructuring charges are expected to be incurred over time, with completion anticipated to occur during fiscal 2030, and will be excluded from adjusted earnings measurements. source

Impact estimates